Research output

  1. Clinicobiological characteristics and treatment efficacy of novel agents in chronic lymphocytic leukemia with IGLV3-21R110

    Research output: Contribution to journal › Article › Academic › peer-review

  2. Minimal residual disease-guided stop and start of venetoclax plus ibrutinib for patients with relapsed or refractory chronic lymphocytic leukaemia (HOVON141/VISION): primary analysis of an open-label, randomised, phase 2 trial

    Research output: Contribution to journal › Article › Academic › peer-review

  3. Genetic care in geographically isolated small island communities: 8 years of experience in the Dutch Caribbean

    Research output: Contribution to journal › Article › Academic › peer-review

View all (34) »

ID: 93978